🇺🇸 FDA
Patent

US 8530489

5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

granted A61PA61P1/00A61P1/02

Quick answer

US patent 8530489 (5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/16, A61P11/06